fostriecin
Term · Oncology and biomedicine · MLC-T-ONC-013770
An anti-tumor antibiotic isolated from the bacterium Streptomyces pulveraceus. Fostriecin inhibits topoisomerase II catalytic activity, resulting in protein-associated strand breaks and impaired DNA and RNA synthesis in various malignant cell types. This agent also inhibits serine/threonine protein phosphatase type 2A in some tumor cell types, thereby interfering with cellular proliferation and differentiation.
| Identifier | MLC-T-ONC-013770 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | FST |
| Synonyms | phosphotrienin |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013770",
"term": "fostriecin",
"field": "Oncology and biomedicine",
"definition": "An anti-tumor antibiotic isolated from the bacterium Streptomyces pulveraceus. Fostriecin inhibits topoisomerase II catalytic activity, resulting in protein-associated strand breaks and impaired DNA and RNA synthesis in various malignant cell types. This agent also inhibits serine/threonine protein phosphatase type 2A in some tumor cell types, thereby interfering with cellular proliferation and differentiation.",
"abbreviation": "FST",
"synonyms": [
"phosphotrienin"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fostriecin/"
}
Record 7,591 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.